Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Cardiology · Heart Failure

Building Your Care Team and Looking Forward

At a Glance

Heart failure outlook varies by its cause, age, kidney function, medical conditions, and response to treatment. A specialized care team can manage symptoms and medicines, while repeated hospital stays, severe symptoms, or hard-to-tolerate medicines may prompt discussion of an LVAD or transplant.

While heart failure is a lifelong journey, you do not have to navigate it alone. Building a specialized care team and understanding your long-term outlook can help you move from a place of uncertainty to a proactive plan for the future.

Your Heart Failure Care Team

Most patients start their journey with a general cardiologist who manages a wide range of heart issues [1]. However, as heart failure becomes more complex, your team may expand to include several key roles:

  • Advanced Heart Failure Specialist: These are cardiologists with extra training specifically in the most complex stages of the disease, including those requiring mechanical pumps or transplants [2].
  • Nurse Educators and Pharmacists: These professionals often provide the most frequent “hands-on” support, helping you master your medication schedule, monitor your labs, and recognize early warning signs [1].
  • Palliative Care Specialists: Unlike hospice (which focuses on the very end of life), palliative care is an extra layer of support that focuses on relieving your symptoms and improving your quality of life at any stage of your illness [3]. They work alongside your cardiologist to help you manage pain, anxiety, or breathlessness while you continue your heart treatments [4].

When to Seek an Advanced Specialist

Doctors often use a conversation prompt to decide when it is time to discuss a referral to an advanced heart failure center. You can remember these potential triggers with the mnemonic I-NEED-HELP [2]:

  • I (Inotropes): You require intravenous medications to keep your heart pumping.
  • N (NYHA Class): You have persistent Class III or IV symptoms (shortness of breath with minimal activity) [2].
  • E (End-organ dysfunction): Your kidney or liver function is worsening [5].
  • E (Ejection Fraction): Your EF is 35% or lower.
  • D (Defibrillator shocks): You have received shocks from an ICD for dangerous heart rhythms [2].
  • H (Hospitalizations): You have been hospitalized for heart failure more than once in the past year [6].
  • E (Edema/Escalation): You need increasing doses of “water pills” to manage your swelling.
  • L (Low blood pressure): Your blood pressure is consistently low (systolic under 90-100 mmHg).
  • P (Progression): You can no longer tolerate your guideline-directed medications because of low blood pressure or kidney issues [2][6].

Note: Having one of these signs does not automatically mean you have advanced, end-stage disease. It simply serves as a prompt for you and your doctor to discuss whether a specialist referral is appropriate based on your overall trajectory.

Understanding Your Outlook

Heart failure is a serious, chronic illness. Historically, population statistics for heart failure survival were guarded. However, older data do not account for the major breakthroughs in modern medical therapy [7][8].

Your individual outlook cannot be predicted by a general statistic. It depends heavily on your age, the specific cause of your heart failure, your kidney function, your other medical conditions, and how your heart responds to treatment [9]. Modern therapies improve symptoms and outcomes for many patients.

For those whose heart failure continues to progress despite optimal medication, advanced therapies may be considered:

  • LVAD (Left Ventricular Assist Device): A mechanical pump implanted in the chest that helps the heart’s main chamber push blood to the rest of the body [10]. This can be a “bridge” to transplant or a permanent solution (destination therapy) [5]. These devices carry trade-offs, such as lifelong infection risk and bleeding considerations.
  • Heart Transplant: Replacing the diseased heart with a donor heart [5][11]. This remains an option for carefully selected patients, requiring rigorous evaluation and lifelong immunosuppression.

By working closely with your team and staying committed to your treatment, you are taking an active role in managing your health and planning for the future [2].

Common questions in this guide

When should I ask for an advanced heart failure specialist?
Consider asking your cardiologist about a referral if you have ongoing severe symptoms, repeated heart-failure hospitalizations, worsening kidney or liver function, an ejection fraction of 35% or less, shocks from an implanted defibrillator, increasing doses of water pills, low blood pressure, or difficulty tolerating recommended medicines. One finding alone does not prove that heart failure is end-stage; the decision depends on your overall course.
Is palliative care the same as hospice for heart failure?
No. Palliative care can be added at any stage while you continue heart failure treatment, and it focuses on symptoms, anxiety, breathlessness, and quality of life. Hospice generally focuses on end-of-life care.
What determines my heart failure outlook?
There is no single statistic that predicts an individual person's future. Outlook depends on factors such as age, the cause of heart failure, kidney function, other health conditions, and how the heart responds to treatment; modern therapies improve symptoms and outcomes for many people.
When might an LVAD or heart transplant be considered?
These options may be discussed when heart failure continues to worsen despite appropriate medicines and other care. An LVAD is a mechanical pump that helps the heart move blood and may support someone while waiting for a transplant or serve as long-term treatment. A transplant is reserved for carefully selected patients and requires lifelong medicines to prevent rejection.
Who can be part of my heart failure care team?
Your team may include a general cardiologist, an advanced heart failure specialist, nurse educators, pharmacists, and palliative care clinicians. Each can help with treatment planning, medicines, monitoring, warning signs, symptom relief, and quality of life.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my current heart failure status warrant a referral to an Advanced Heart Failure specialist, or is my care best managed by my current cardiologist?
  2. 2.How many heart failure patients does this clinic manage, and do you have dedicated nurse educators or pharmacists on the team?
  3. 3.If my kidney function or blood pressure starts to drop, what is our plan for adjusting my medications before considering me 'intolerant'?
  4. 4.What is your experience with advanced therapies like LVADs or transplants, and at what point would we start that evaluation?
  5. 5.Can we involve a palliative care specialist now to help with my current symptoms and quality of life, even while we are aggressively treating my heart?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    Heidenreich PA, Bozkurt B, Aguilar D, et al.

    Journal of the American College of Cardiology 2022; (79(17)):e263-e421 doi:10.1016/j.jacc.2021.12.012.

    PMID: 35379503
  2. 2

    Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association.

    Morris AA, Khazanie P, Drazner MH, et al.

    Circulation 2021; (144(15)):e238-e250 doi:10.1161/CIR.0000000000001016.

    PMID: 34503343
  3. 3

    Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices.

    Luo N, Rogers JG, Dodson GC, et al.

    The American journal of cardiology 2016; (118(5)):733-8.

    PMID: 27474339
  4. 4

    Psychosocial Evaluation of Candidates for Heart Transplant and Ventricular Assist Devices: Beyond the Current Consensus.

    Bui QM, Allen LA, LeMond L, et al.

    Circulation. Heart failure 2019; (12(7)):e006058 doi:10.1161/CIRCHEARTFAILURE.119.006058.

    PMID: 31213069
  5. 5

    Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

    Crespo-Leiro MG, Metra M, Lund LH, et al.

    European journal of heart failure 2018; (20(11)):1505-1535 doi:10.1002/ejhf.1236.

    PMID: 29806100
  6. 6

    Patient Selection for Destination LVAD Therapy: Predicting Success in the Short and Long Term.

    Michaels A, Cowger J

    Current heart failure reports 2019; (16(5)):140-149 doi:10.1007/s11897-019-00434-1.

    PMID: 31240639
  7. 7

    Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.

    Shah KS, Xu H, Matsouaka RA, et al.

    Journal of the American College of Cardiology 2017; (70(20)):2476-2486 doi:10.1016/j.jacc.2017.08.074.

    PMID: 29141781
  8. 8

    Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.

    Santas E, Valero E, Mollar A, et al.

    Revista espanola de cardiologia (English ed.) 2017; (70(4)):239-246 doi:10.1016/j.rec.2016.06.021.

    PMID: 27816423
  9. 9

    Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

    Martin N, Manoharan K, Thomas J, et al.

    The Cochrane database of systematic reviews 2018; (6()):CD012721 doi:10.1002/14651858.CD012721.pub2.

    PMID: 29952095
  10. 10

    A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation.

    Kanwar MK, Lohmueller LC, Kormos RL, et al.

    JACC. Heart failure 2018; (6(9)):771-779 doi:10.1016/j.jchf.2018.03.016.

    PMID: 30098967
  11. 11

    Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.

    Guglin M, Zucker MJ, Borlaug BA, et al.

    Journal of the American College of Cardiology 2020; (75(12)):1471-1487 doi:10.1016/j.jacc.2020.01.034.

    PMID: 32216916

This page is for informational purposes only and does not constitute medical advice. Discuss heart failure referrals, prognosis, and treatment options with your cardiologist or care team.

Get notified when new evidence is published on congestive heart failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.